Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma(Clin Cancer Res (2015)21(30–8)DOI: 10.1158/1078-0432.CCR-14-1716)

Joseph A. Califano, Zubair Khan, Kimberly A. Noonan, Lakshmi Rudraraju, Zhe Zhang, Hao Wang, Steven Goodman, Christine G. Gourin, Patrick K. Ha, Carole Fakhry, John Saunders, Marshall Levine, Mei Tang, Geoffrey Neuner, Jeremy D. Richmon, Ray Blanco, Nishant Agrawal, Wayne M. Koch, Shanthi Marur, Donald T. WeedPaolo Serafini, Ivan Borrello

Research output: Contribution to journalComment/debate

Abstract

In the original version of this article (1), the authors did not disclose that the investigational agent used, tadalafil, was supplied by Lilly, Inc. This information is now included in the Acknowledgements. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume24
Issue number23
DOIs
StatePublished - Dec 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma(Clin Cancer Res (2015)21(30–8)DOI: 10.1158/1078-0432.CCR-14-1716)'. Together they form a unique fingerprint.

  • Cite this

    Califano, J. A., Khan, Z., Noonan, K. A., Rudraraju, L., Zhang, Z., Wang, H., Goodman, S., Gourin, C. G., Ha, P. K., Fakhry, C., Saunders, J., Levine, M., Tang, M., Neuner, G., Richmon, J. D., Blanco, R., Agrawal, N., Koch, W. M., Marur, S., ... Borrello, I. (2018). Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma(Clin Cancer Res (2015)21(30–8)DOI: 10.1158/1078-0432.CCR-14-1716). Clinical Cancer Research, 24(23). https://doi.org/10.1158/1078-0432.CCR-18-3298